<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended November 30, 2000
-----------------
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
------------------- ----------------------
Commission File No. 0-11488
-------
Penford Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Washington 91-1221360
--------------------------------------------------------------------------------
(State of Incorporation) (I.R.S. Employer
Identification No.)
777-108th Avenue N.E., Suite 2390, Bellevue, WA 98004-5193
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (425) 462-6000
--------------
Indicate by a check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes X No
----- -----
Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of January 5, 2001.
Class Outstanding
----- -----------
Common stock, par value $1.00 7,457,347
1
<PAGE> 2
PENFORD CORPORATION AND SUBSIDIARIES
INDEX
Page No.
--------
PART I - FINANCIAL INFORMATION
Item 1 - Financial Statements
Condensed Consolidated Balance Sheets 3
November 30, 2000 and August 31, 2000
Condensed Consolidated Statements of Income 4
Three Months Ended November 30, 2000 and
November 30, 1999
Condensed Consolidated Statements of Cash Flow 5
Three Months Ended November 30, 2000 and
November 30, 1999
Notes to Condensed Consolidated Financial Statements 6-11
Item 2 - Management's Discussion and Analysis of 12-14
Financial Condition and Results of Operations
Item 3 - Quantitative and Qualitative Disclosures 15
About Market Risk
PART II - OTHER INFORMATION
Item 1 - Legal Proceedings 16
Item 2 - Changes in Securities 16
Item 3 - Defaults Upon Senior Securities 16
Item 4 - Submission of Matters to a Vote of Security Holders 16
Item 5 - Other Information 16
Item 6 - Exhibits and Reports on Form 8-K 16-19
SIGNATURES 20
2
<PAGE> 3
PART I - FINANCIAL INFORMATION
Item 1 Financial Statements
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Dollars in thousands)
<TABLE>
<CAPTION>
November 30, August 31,
2000 2000
------------ ----------
<S> <C> <C>
ASSETS
Current assets:
Cash and cash equivalents $ 37 $ --
Trade accounts receivable 29,052 17,530
Inventories:
Raw materials and other 10,182 3,016
Work in progress 420 502
Finished goods 13,108 6,701
--------- ---------
23,710 10,219
Prepaid expenses and other 7,089 5,580
--------- ---------
Total current assets 59,888 33,329
Net property, plant and equipment 143,397 114,848
Deferred income taxes 11,467 11,466
Restricted cash value of life insurance 12,449 12,330
Other assets 3,801 3,650
Goodwill, net 18,557 --
--------- ---------
Total assets $ 249,559 $ 175,623
========= =========
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Bank overdraft, net $ -- $ 313
Accounts payable 16,673 10,068
Accrued liabilities 7,782 8,305
Current portion of long-term debt 10,925 2,857
--------- ---------
Total current liabilities 35,380 21,543
Long-term debt 105,672 47,824
Other postretirement benefits 10,867 10,805
Deferred income taxes 22,438 21,048
Other liabilities 7,970 6,539
Shareholders' equity:
Common stock 9,435 9,392
Additional paid-in capital 23,630 23,129
Retained earnings 68,858 68,100
Treasury stock (32,757) (32,757)
Accumulated other comprehensive income (loss) (1,934) --
--------- ---------
Total shareholders' equity 67,232 67,864
--------- ---------
Total liabilities and shareholders' equity $ 249,559 $ 175,623
========= =========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
3
<PAGE> 4
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Dollars in thousands except per share data)
<TABLE>
<CAPTION>
Three Months Ended November 30
------------------------------
2000 1999
---- ----
<S> <C> <C>
Sales $ 46,853 $ 40,553
Cost of sales 35,900 29,487
----------- -----------
Gross margin 10,953 11,066
Operating expenses 5,139 4,595
Research and development 1,650 1,372
----------- -----------
Income from operations 4,164 5,099
Interest expense (2,333) (1,276)
----------- -----------
Income before taxes 1,831 3,823
Income taxes 626 1,338
----------- -----------
Net income $ 1,205 $ 2,485
=========== ===========
Weighted average common shares
and equivalents outstanding 7,660,604 7,709,616
Earnings per common share:
Net income
Basic $ 0.16 $ 0.33
=========== ===========
Diluted $ 0.16 $ 0.32
=========== ===========
Dividends declared per common share $ 0.06 $ 0.05
=========== ===========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
4
<PAGE> 5
PENFORD CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Dollars in thousands)
<TABLE>
<CAPTION>
Three Months Ended November 30
------------------------------
2000 1999
---- ----
<S> <C> <C>
Operating Activities:
Net Income $ 1,205 $ 2,485
Adjustments to reconcile net income
to net cash from operations:
Depreciation 4,140 3,311
Deferred income taxes 237 (141)
Change in operating assets and liabilities
excluding impact of Penford Australia
Limited acquisition:
Trade receivables (1,948) (2,521)
Inventories (1,081) 12
Accounts payable, prepaids and other (840) 1,310
--------- ---------
Net cash from operating activities 1,713 4,456
Investing Activities:
Additions to property, plant and equipment, net (3,053) (3,741)
Acquisition of Penford Australia Limited (59,113) --
Other 306 481
--------- ---------
Net cash used by investing activities (61,860) (3,260)
Financing Activities:
Proceeds from revolving line of credit 23,163 13,795
Payments on revolving line of credit (17,806) (11,435)
Proceeds from long-term debt 106,509 --
Payments on long-term debt (50,571) (3,067)
Exercise of stock options 474 30
Purchase of treasury stock -- (209)
Payment of dividends (891) (369)
--------- ---------
Net cash provided (used) by financing
activities 60,878 (1,255)
Effect of exchange rate changes on cash and
cash equivalents (381) --
--------- ---------
Net increase (decrease) in cash and equivalents 350 (59)
Cash and cash equivalents (bank overdraft) at
beginning of period (313) 15
--------- ---------
Cash and cash equivalents (bank overdraft) at
end of period $ 37 $ (44)
========= =========
</TABLE>
See accompanying notes to condensed consolidated financial statements.
5
<PAGE> 6
PENFORD CORPORATION AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
1. BUSINESS
Penford Corporation ("Penford" or the "Company") is in the business of
developing, manufacturing and marketing specialty carbohydrate-based
ingredient systems for various applications, including papermaking,
textiles and food products. The Company operates manufacturing
facilities in the United States, Australia, and New Zealand. Penford's
products provide excellent binding and film-forming characteristics that
make customers' products better through natural, convenient and cost
effective solutions. Sales of the Company's products are generated using
a combination of direct sales and distributor agreements.
The Company has extensive research and development capabilities, which
are used in understanding the complex chemistry of carbohydrate-based
materials and their application. In addition, the Company has specialty
processing capabilities for a variety of modified starches, all of which
have similar production methods.
2. BASIS OF PRESENTATION
The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with generally accepted accounting
principles for interim financial information and with the instructions
to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, they do not
include all of the information and footnotes required by generally
accepted accounting principles for complete financial statements. In the
opinion of management, all adjustments (consisting of normal recurring
accruals) considered necessary for a fair presentation of the interim
period presented have been included. The preparation of financial
statements in conformity with generally accepted accounting principles
requires management to make estimates and assumptions that affect the
amounts reported in the financial statements and accompanying notes.
Actual results could differ from those estimates. Operating results for
the three month period ended November 30, 2000 are not necessarily
indicative of the results that may be expected for the year ending
August 31, 2001. For further information, refer to the consolidated
financial statements and footnotes thereto included in Penford
Corporation's annual report on Form 10-K for the fiscal year ended
August 31, 2000.
6
<PAGE> 7
3. RECENT ACCOUNTING DEVELOPMENTS
Effective September 1, 2000, the Company adopted Statement of Financial
Accounting Standards ("SFAS") No. 133, "Accounting for Derivative
Instruments and Hedging Activities". SFAS No. 133 establishes standards
for recognition and measurement of derivatives and hedging activities.
As a result of this adoption, the Company recorded in the first quarter
of fiscal 2001 the cumulative effect of change in accounting principle
to other comprehensive income of $0.3 million ($0.2 million after-tax)
for derivatives which hedge the variable cash flows of certain
forecasted transactions. The fair value of these derivate instruments
was previously classified in inventory.
4. ACQUISITION OF PENFORD AUSTRALIA LIMITED
On September 29, 2000, Penford Corporation completed its acquisition of
Starch Australasia Limited from Goodman Fielder Limited for $54.5
million (USD) in cash, plus costs incurred directly related to the
acquisition of approximately $4.6 million (USD), including accounting,
financing, taxation, legal and other due diligence efforts. Starch
Australasia Limited, renamed Penford Australia Limited ("Penford
Australia"), is Australia's sole producer of corn starch products and a
world leader in the research, development and commercialization of novel
starch-based products. Penford Australia manufactures products used to
enhance the functionality of packaged food products, as well as products
used in the mining and paper industries. Its operations include three
manufacturing facilities, two in Australia and one in New Zealand, for
processing specialty corn starches and wheat related products.
The acquisition was recorded using the purchase method of accounting.
Accordingly, a portion of the purchase price was allocated to net
tangible and intangible assets acquired based on their estimated fair
values. The balance of the purchase price was recorded as goodwill,
which is being amortized over a twenty year period. Two months of
Penford Australia's results of operations, from the September 29, 2000
date of acquisition, are included in the consolidated financial
statements for the fiscal quarter ended November 30, 2000.
In connection with the completion of the acquisition of Penford
Australia, the Company obtained interim financing for replacing its
credit facilities. As a result, except for a $5 million uncommitted line
of credit that remained in place, all outstanding debt as of August 31,
2000, was replaced by a $120 million bridge loan with a syndicate of
banks, consisting of the same three banks responsible for the previous
$75 million unsecured credit facility. The new borrowings totaling
$109.5 million under the bridge loan were used to finance the
acquisition, in addition to replacing the existing outstanding debt
balances.
7
<PAGE> 8
4. ACQUISITION OF PENFORD AUSTRALIA LIMITED (CONTINUED)
Subsequent to the consummation of the purchase transaction, a new $130
million credit facility was completed on November 15, 2000, with the
aforementioned syndicate of banks, including the addition of an
Australian bank. The new credit facility consists of various agreements
with $65 million in term loans and $65 million of revolving lines of
credit. The revolving lines of credit expire on October 31, 2003, and
the term loans expire on October 31, 2005. Borrowing rates available to
the Company under the entire credit facility are based on the LIBOR or
prime rate depending on the selection of borrowing options. All of
Penford's assets secure the credit facility and the new agreements
include, among other terms, financial covenants with limitations on
indebtedness, minimum net worth and maintenance of certain leverage,
interest and fixed charge coverage ratios. All of the financial
covenants are similar to restrictions on the existing debt as of August
31, 2000.
The following unaudited pro forma financial information presents the
combined results of operations of the Company and Penford Australia, as
if the acquisition had occurred on September 1, 1999. The unaudited pro
forma financial information does not necessarily reflect the results of
operations that would have occurred had the Company and Penford
Australia constituted a single entity during such periods (Dollars in
thousands except per share data):
<TABLE>
<CAPTION>
Three Months Ended
November 30
---------------------
2000 1999
---- ----
<S> <C> <C>
Sales $53,484 $59,671
Net income $ 1,281 $ 2,607
Net income per share
Basic $ .17 $ .35
======= =======
Diluted $ .17 $ .34
======= =======
</TABLE>
8
<PAGE> 9
5. COMPREHENSIVE INCOME
SFAS No. 130 establishes the standards for reporting and displaying
comprehensive income and its components in the financial statements. The
components of comprehensive income (loss) for the periods ended November
30, 2000 and 1999 are as follows (Dollars in thousands):
<TABLE>
<CAPTION>
Three Months Ended
November 30
------------------
2000 1999
---- ----
<S> <C> <C>
Net income $ 1,205 $2,485
Cumulative effect of change in accounting
principle - FAS 133 (Note 3) $ 189 $ -
Foreign currency translation adjustments $(2,123) $ -
------- ------
Comprehensive income (loss) $ (729) $2,485
======= ======
</TABLE>
The foreign currency translation adjustment reflects the translation of
the Company's investment in its Australian operations to U.S. dollars
from Australian dollars. The foreign currency exchange rates as of
September 29, 2000, the date of acquisition, and November 30, 2000 were
$0.542 and $0.521 U.S. dollars to the Australian dollar, respectively.
9
<PAGE> 10
6. SEGMENT REPORTING
The Company operates in one business segment: developing, manufacturing,
and marketing specialty carbohydrate-based ingredient systems for
various applications.
Information about the Company's operations by geographic area, including
its operations in North America and its recently acquired business in
Australia and New Zealand, follows (Dollars in thousands):
<TABLE>
<CAPTION>
Three Months Ended
November 30
------------------------
2000 1999
---- ----
<S> <C> <C>
Sales
- North America $ 37,409 $ 40,553
- Australia/New Zealand 9,444 --
-------- --------
$ 46,853 $ 40,553
======== ========
Net Income
- North America $ 793 $ 2,485
- Australia/New Zealand 412 --
-------- --------
$ 1,205 $ 2,485
======== ========
</TABLE>
<TABLE>
<CAPTION>
November 30, 2000 August 31, 2000
----------------- ---------------
<S> <C> <C>
Total Assets
- North America $177,901 $175,623
- Australia/New Zealand 71,658 --
-------- --------
$249,559 $175,623
======== ========
</TABLE>
10
<PAGE> 11
7. EARNINGS PER COMMON SHARE
The following table presents the computation of basic and diluted
earnings per share (Dollars in thousands except per share data):
<TABLE>
<CAPTION>
Three Months Ended
November 30
-----------------------
2000 1999
---- ----
<S> <C> <C>
Net income $ 1,205 $ 2,485
========= =========
Weighted average common
shares outstanding 7,434,047 7,424,711
Net effect of dilutive
stock options 226,557 284,905
--------- ---------
Weighted average common shares
outstanding assuming dilution 7,660,604 7,709,616
========= =========
Earnings per common share:
Net income
Basic $ 0.16 $ 0.33
========= =========
Diluted $ 0.16 $ 0.32
========= =========
</TABLE>
Basic earnings per share reflects only the weighted average common
shares outstanding. Diluted earnings per share reflects weighted average
common shares outstanding and the effect of any dilutive common stock
equivalent shares.
11
<PAGE> 12
Item 2 MANAGEMENT'S DISCUSSION AND ANALYSIS
OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
RECENT ACQUISITION
On September 29, 2000, Penford Corporation completed its acquisition of Starch
Australasia Limited, renamed Penford Australia Limited ("Penford Australia"),
from Goodman Fielder Limited for $54.5 million (USD) in cash, plus costs of $4.6
million directly related to the acquisition. Two months of Penford Australia's
results of operations are included in the Company's condensed consolidated
financial statements for the quarter ended November 30, 2000.
Penford Australia is Australia's sole producer of corn starch products and a
world leader in the research, development and commercialization of novel
starch-based products. Penford Australia manufactures products used to enhance
the functionality of packaged food products, as well as products used in the
mining and paper industries. Its operations include three manufacturing
facilities, two in Australia and one in New Zealand, for processing specialty
corn starches and wheat related products.
RESULTS OF CONTINUING OPERATIONS
In the three months ended November 30, 2000, Penford Corporation's consolidated
sales increased $6.3 million, or 15.5%, to $46.9 million. The increase from
$40.6 million in the prior year is primarily due to the acquisition of Penford
Australia and higher sales volume of the Company's specialty starch-based
ingredient systems for the food industry. However, sales volumes for paper
customers decreased approximately 8.3% caused by a softened demand in the North
American paper industry suppressing overall sales growth.
Sales revenue and volumes of specialty potato-based food starches increased 8.8%
and 11.8%, respectively, in the first quarter of fiscal 2001 ending November 30,
2000 over the same period a year ago. The increase over last year's strong
quarter was primarily due to solid performance in both coating and processed
meat applications.
Gross margin for the three months ended November 30, 2000 was 23.4% compared to
27.3% for the corresponding period a year ago. Total gross margin for the three
months ended November 30, 2000 was $11.0 million compared to $11.1 million for
the corresponding period a year ago. Total gross margin dollars in the first
three months of fiscal 2001 remained consistent with the same prior year period
primarily due to higher natural gas costs in North America which significantly
impacted manufacturing costs, being offset by the addition of the higher margin
Penford Australia operation and increased demand for specialty food ingredients.
The decrease in gross margin percentage was primarily due to higher natural gas
costs, and to a lesser extent, the inclusion of Penford Australia.
Operating expenses in the first quarter of $5.1 million were approximately
$544,000 higher compared to the same quarter in the prior year. Research and
development expenses increased $278,000 in the three months ended November 30,
2000 over the same period a
12
<PAGE> 13
year ago. The increases in operating and research and development expenses are
primarily due to the inclusion of Penford Australia in the Company's overall
results.
Net interest expense was $2.3 million for the three months ended November 30,
2000 compared to $1.3 million in the same period in fiscal 2000. The increase is
attributed to higher debt balances as a result of the acquisition of Penford
Australia.
The effective tax rate for the first quarter of fiscal 2001 and 2000 was 34.2%
and 35.0%, respectively. The slightly lower effective tax rate in the current
fiscal year reflects Australia's current statutory tax rate of 34%, decreasing
to 30% in July 2001.
Net income was $1.2 million, or $0.16 per share assuming dilution, for the three
months ended November 30, 2000, compared to net income of $2.5 million, or $0.32
per share assuming dilution, for the corresponding period a year ago.
LIQUIDITY AND CAPITAL RESOURCES
In connection with the completion of the acquisition of Penford Australia on
September 29, 2000, the Company obtained interim financing for replacing its
credit facilities. As a result, except for a $5 million uncommitted line of
credit that remained in place, all outstanding debt as of August 31, 2000, was
replaced by a $120 million bridge loan with a syndicate of banks, consisting of
the same three banks responsible for the previous $75 million unsecured credit
facility. The new borrowings totaling $109.5 million under the bridge loan were
used to finance the acquisition, in addition to replacing the existing
outstanding debt balances.
Subsequent to the consummation of the purchase transaction, a new $130 million
credit facility was completed on November 15, 2000, with the aforementioned
syndicate of banks, including the addition of an Australian bank. The new credit
facility consists of various agreements with $65 million in term loans and $65
million of revolving lines of credit. The revolving lines of credit expire on
October 31, 2003, and the term loans expire on October 31, 2005. Borrowing rates
available to the Company under the entire credit facility are based on the LIBOR
or prime rate depending on the selection of borrowing options. All of Penford's
assets secure the credit facility and the new agreements include, among other
terms, financial covenants with limitations on indebtedness, minimum net worth
and maintenance of certain leverage, interest and fixed charge coverage ratios.
All of the financial covenants are similar to restrictions on the existing debt
as of August 31, 2000.
At November 30, 2000, Penford had working capital of $24.5 million and $46.5
million outstanding under the $65 million revolving line of credit. The Company
also has a $5 million uncommitted line of credit under which there was $1.3
million outstanding. In the first quarter of fiscal 2001, the Company used its
debt proceeds and operating cash flow to finance the purchase of Penford
Australia and other capital expenditures.
Cash flow from operations for the quarter ended November 30, 2000 was $1.7
million compared to $4.5 million in the corresponding quarter of the prior year.
The decrease in operating cash flow is due to lower quarterly earnings and
fluctuations in the components of working capital.
13
<PAGE> 14
Additions to property, plant and equipment during the three months ended
November 30, 2000 were $3.1 million. First quarter additions were primarily for
various improvements at the Company's industrial facility in Cedar Rapids, Iowa
and equipment additions and improvements at all of the Company's food-grade
manufacturing facilities.
The Company began paying a quarterly cash dividend of $0.05 per share in 1992
and has continued to pay quarterly dividends ever since. On April 3, 2000, the
Board of Directors approved an increase in the quarterly cash dividend to $0.06
per share.
The Board of Directors has authorized a stock repurchase program for the
purchase of up to 500,000 shares of the outstanding common stock of the Company.
Repurchases under the program to date have totaled 281,300 shares for $4.3
million, although the Company did not purchase any of its common stock during
the first quarter of fiscal 2001.
FORWARD-LOOKING STATEMENTS
This report contains forward-looking statements concerning the performance and
results of the Company. There are a variety of factors which could cause actual
events or results to differ materially from those projected in the
forward-looking statements, including, without limitation, competition; the
possibility of interruption of business activities due to equipment problems,
accidents, strikes, weather or other factors; product development risk; changes
in corn and other raw material prices; changes in general economic conditions or
developments with respect to specific industries or customers affecting demand
for the Company's products including unfavorable shifts in product mix;
unanticipated costs, expenses or third party claims; the risk that results may
be affected by construction delays, cost overruns, technical difficulties,
nonperformance by contractors or changes in capital improvement project
requirements or specifications; interest rate and energy cost volatility;
foreign currency exchange rate fluctuations; or other unforeseen developments in
the industries in which the Company operates. Accordingly, there can be no
assurance that future activities or results will be as anticipated.
Forward-looking statements are based on the estimates and opinions of management
on the date the statements are made. The Company assumes no obligation to update
any forward-looking statements if circumstances or management's estimates or
opinions should change.
Additional information which could affect the Company's financial results is
included in the Company's 2000 Annual Report to Shareholders and its Form 10-K
for the fiscal year ended August 31, 2000 on file with the Securities and
Exchange Commission.
14
<PAGE> 15
Item 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK
MARKET RISK SENSITIVE INSTRUMENTS AND POSITIONS
The market risk associated with the Company's market risk sensitive instruments
is the potential loss from adverse changes in interest rates, foreign currency
exchange rates, and commodities prices.
The Company is unaware of any material changes to the market risk disclosures
referred to in the Company's Report on Form 10-K for the year ended August 31,
2000, other than the increase in the amount of borrowings undertaken principally
to finance the acquisition of Penford Australia.
15
<PAGE> 16
PART II - OTHER INFORMATION
Item 1 Legal Proceedings
A complaint was filed in late November 1999 against Penford in the
United States District Court for the District of Idaho, alleging
various violations of the Federal Clean Air Act, as well as claims
for trespass and nuisance by alleged emissions from Penford's Idaho
Falls starch processing plant. The subject of the complaint involves
alleged excessive starch emissions that occurred in 1996 and 1997,
which were previously disclosed by the Company, and certain other
alleged violations relating to the plant. The complaint sought civil
penalties, together with private damages. By agreement of the
Parties, the Federal Clean Air Act claims have been dismissed with
prejudice. Non-binding mediation for the remaining trespass and
nuisance claims was tentatively scheduled for February, 2001.
In December 2000, the plaintiffs filed an amended complaint adding
several new plaintiffs, adding claims for emotional distress and
outrage, and purporting to re-assert the Clean Air Act Claims on
behalf of the new plaintiffs. Penford is currently preparing papers
seeking to dismiss the Clean Air Act claims.
Item 2 Changes in Securities
Not applicable
Item 3 Defaults Upon Senior Securities
Not applicable
Item 4 Submission of Matters to a Vote of Security Holders
Not applicable
Item 5 Other Information
Not applicable
Item 6 Exhibits and Reports on Form 8-K.
(a) Exhibits:
(2.1) Starch Australasia Share Sale Agreement completed as of
September 29, 2000 among Penford Holdings Pty Limited, a
wholly owned subsidiary of Registrant, and Goodman Fielder
Limited (filed as an exhibit to Registrant's Form 8-K/A
dated September 29, 2000)
(3.1) Restated Articles of Incorporation of Registrant (filed
as an exhibit to Registrant's Form 10-K for fiscal year
ended August 31, 1995)
(3.2) Articles of Amendment to Restated Articles of
Incorporation of Registrant (filed as an exhibit to
Registrant's Form 10-K for fiscal year ended August 31,
1997)
16
<PAGE> 17
(3.3) Bylaws of Registrant as amended and restated as of October
20, 1997 (filed as an exhibit to Registrant's Form 10-K
for fiscal year ended August 31, 1997)
(4.1) Amended and Restated Rights Agreement dated as of April
30, 1997 (filed as an exhibit to Registrant's Amendment to
Registration Statement on Form 8-A/A dated May 5, 1997)
(10.1) Penford Corporation Supplemental Executive Retirement
Plan, dated March 19, 1990 (filed as an exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1991)
(10.2) Penford Corporation Supplemental Survivor Benefit Plan,
dated January 15, 1991 (filed as an exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1991)
(10.3) Penford Corporation Deferred Compensation Plan, dated
January 15, 1991 (filed as an exhibit to Registrant's Form
10-K for the fiscal year ended August 31, 1991)
(10.4) Change of Control Agreements between Penford Corporation
and Messrs. Cook, Horn, Keeley, and Kunerth (a
representative copy of these agreements is filed as an
exhibit to Registrant's Form 10-K for the fiscal year
ended August 31, 1995)
(10.5) Penford Corporation 1993 Non-Employee Director Restricted
Stock Plan (filed as an exhibit to Registrant's Form 10-Q
for the quarter ended November 30, 1993)
(10.6) Penford Corporation 1994 Stock Option Plan as amended and
restated as of January 21, 1997 (filed on Form S-8 dated
March 17, 1997)
(10.7) Penford Corporation Stock Option Plan for Non-Employee
Directors (filed as an exhibit to the Registrant's Form
10-Q for the quarter ended May 31, 1996)
(10.8) Separation Agreement dated as of July 31, 1998 between
Registrant and Penwest Pharmaceuticals Co. (filed as an
exhibit to Registrant's Form 8-K dated August 31, 1998)
(10.9) Services Agreement dated as of July 31, 1998 between
Registrant and Penwest Pharmaceuticals Co. (filed as an
exhibit to Registrant's Form 8-K dated August 31, 1998)
(10.10) Employee Benefits Agreement dated as of July 31, 1998
between Registrant and Penwest Pharmaceuticals Co.
(filed as an exhibit to Registrant's Form 8-K dated
August 31, 1998)
(10.11) Tax Allocation Agreement dated as of July 31, 1998 between
Registrant and Penwest Pharmaceuticals Co. (filed as an
exhibit to Registrant's Form 8-K dated August 31, 1998)
(10.12) Excipient Supply Agreement dated as of July 31, 1998
between Registrant and Penwest Pharmaceuticals Co.
(filed as an exhibit to Registrant's Form 8-K dated
August 31, 1998)
17
<PAGE> 18
(10.13) Restatement and Exchange Agreement amending the Senior
Note Agreement among Penford Corporation as Borrower and
Mutual of Omaha and Affiliates as lenders, dated as of
August 1, 1998 (filed as an exhibit to Registrant's Form
10-K for the fiscal year ended August 31, 1998)
(10.14) Guaranty Agreement dated as of August 1, 1998 by Penford
Products Co., a wholly-owned subsidiary of Registrant, of
the Restatement and Exchange Agreement among Registrant
and Mutual of Omaha and Affiliates (filed as an exhibit to
Registrant's Form 10-K for the fiscal year ended August
31, 1998)
(10.15) Restatement and Exchange Agreement amending the Senior
Note Agreement among Penford Corporation as Borrower, and
Principal Mutual Life Insurance Company and TMG Life
Insurance Company as lenders, dated as of August 1, 1998
(filed as an exhibit to Registrant's Form 10-K for the
fiscal year ended August 31, 1998)
(10.16) Guaranty Agreement dated as of August 1, 1998 by Penford
Products Co., a wholly owned subsidiary of Registrant, of
the Restatement and Exchange Agreement among Registrant,
Principal Mutual Life Insurance Company, and TMG Life
Insurance Company (filed as an exhibit to Registrant's
Form 10-K for the fiscal year ended August 31, 1998)
(10.17) Credit Agreement dated as of July 2, 1998 among Penford
Corporation and Penford Products Co. as borrowers, and
certain commercial lending institutions as the lenders,
and The Bank of Nova Scotia, as agent for the lenders
(filed as an exhibit to Registrant's Form 10-K for the
fiscal year ended August 31, 1998)
(10.18) Intercreditor Agreement dated as of August 1, 1998 among
the parties to the Credit Agreement dated July 2, 1998 and
the parties to the Senior Note Agreements dated as of
August 1, 1998 (filed as an exhibit to Registrant's Form
10-K for the fiscal year ended August 31, 1998)
(10.19) Amended and Restated Credit Agreement dated as of November
15, 2000 among Penford Corporation and Penford Products
Co. as borrowers, and certain commercial lending
institutions as lenders, and the Bank of Nova Scotia, as
agent for the lenders (filed as an exhibit to Registrant's
Form 8-K/A dated September 29, 2000)
(10.20) Debenture Trust Deed dated as of November 15, 2000 among
Penford Holdings Pty Limited as issuer and ANZ Capel Court
Limited as trustee (filed as an exhibit to Registrant's
Form 8-K/A dated September 29, 2000)
(10.21) Syndicated Facility Agreement dated as of November 15,
2000 among Penford Australia Limited, a wholly owned
subsidiary of Penford Holdings Pty Limited, as borrowers,
and Australia and New Zealand Banking Group Limited as
lender and agent (filed as an exhibit to Registrant's Form
8-K/A dated September 29, 2000)
18
<PAGE> 19
(10.22) Intercreditor Agreement dated as of November 15, 2000 by
and among The Bank of Nova Scotia, KeyBank National
Association, U.S. National Association and Australia and
New Zealand Banking Group Limited (filed as an exhibit to
Registrant's Form 8-K/A dated September 29, 2000)
27 Financial Data Schedule
(b) Reports on Form 8-K
A Form 8-K dated August 29, 2000 was filed reporting under
Item 5, Registrant's intention to acquire Starch
Australasia Limited from Goodman Fielder Limited on
September 29, 2000. Filed as an exhibit was a copy of the
press release dated August 29, 2000.
A Form 8-K dated September 29, 2000 was filed reporting
under Item 2, Registrant's completion of its acquisition
of Starch Australasia Limited from Goodman Fielder
Limited. Filed as an exhibit was a copy of the press
release dated September 29, 2000. In accordance with
paragraph 4 of Item 7(a) of Form 8-K, the required
financial statements and pro forma financial information
were filed by amendment on December 12, 2000.
19
<PAGE> 20
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Penford Corporation
------------------------------------------
(Registrant)
January 16, 2001 /s/ Jeffrey T. Cook
---------------- ------------------------------------------
Date Jeffrey T. Cook
President and
Chief Executive Officer (Principal
Executive Officer)
January 16, 2001 /s/ Keith T. Fujinaga
---------------- ------------------------------------------
Date Keith T. Fujinaga
Corporate Director of Finance
(Chief Accounting Officer)
20
